AzTrials
AzTrials

Smoking CessationNCT07775755

Virtual Reality (VR)and Mobile-Based Smoking Cessation in Breastfeeding Mothers

A study testing Virtual Reality and Mobile Application-Based Smoking Cessation Education in people with Smoking Cessation and Tobacco Use Disorder, run by Kahramanmaras Sutcu Imam University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized controlled trial was conducted to evaluate the effect of an educational video delivered through virtual reality (VR) glasses and a mobile application on smoking cessation behavior among breastfeeding mothers. Read more about this study

Who is it for?
Ages 18 years and older, women only
What is being tested?
Virtual Reality and Mobile Application-Based Smoking Cessation Education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
76 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jan 2026to 1 Jan 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Mother must be 18 years of age or older
  • Mothers who have a baby aged 0-6 months and are breastfeeding
  • Smoking
  • Mother and baby must be healthy
  • Mother must own a smartphone and be able to use it
  • Volunteer to participate in the study (Volunteering by signing the Informed Consent Form)
  • Having a low level of dependence according to the FNTD score (having scored 3 points or higher),
  • Not having Postpartum Depression according to the EPDS score (having scored below 12 points).

Who cannot join

  • Mother or baby having a health problem
  • Having communication problems

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Tarsus State Hospital

    Tarsus, Mersin, 33460

Other trials in Turkey (Türkiye)

About this study

Official title: Investigation of the Effect of Educational Video Watched With Virtual Reality Glasses and Mobile Application on Smoking Cessation in Breastfeeding Mothers

This randomized controlled trial was conducted to evaluate the effect of an educational video delivered through virtual reality (VR) glasses and a mobile application on smoking cessation behavior among breastfeeding mothers.

The study was carried out in the breastfeeding outpatient clinic of a secondary-level public hospital. A total of 76 breastfeeding mothers with infants aged 0-6 months who reported active cigarette smoking were enrolled. Participants were randomly assigned to either an intervention group (n = 35) or a control group (n = 41) using a simple randomization method. Mothers in the intervention group viewed an educational video through VR glasses and a mobile application that provided evidence-based information on the harmful effects of smoking on maternal and infant health and encouraged smoking cessation. The control group received routine breastfeeding care and counseling provided by the clinic.

Participants were followed for six months, with assessments performed at baseline and at the 1st, 2nd, 4th, and 6th months after the intervention. Data were collected using the Personal Information Form, the Fagerström Test for Nicotine Dependence, and the Questionnaire of Smoking Urges-Brief. The primary objective was to evaluate changes in nicotine dependence and smoking urges over the follow-up period and to determine the effectiveness of the VR- and mobile application-based educational intervention in supporting smoking cessation among breastfeeding mothers.

Being tested
Virtual Reality and Mobile Application-Based Smoking Cessation Education
Keywords
Breastfeeding Mother, Quitting Smoking, Virtual Reality, Mobile Application, Nicotine Dependence
Medical subject headings
Smoking Cessation, Tobacco Use Disorder, Breast Feeding

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual Reality and Mobile Application-Based Smoking Cessation EducationBehavioural

    Participants in the intervention group viewed an educational video on smoking cessation using virtual reality (VR) glasses and a mobile application.

Study groups in NCT07775755
Study groupRoleWhat they receive
Experimental GroupExperimentalBreastfeeding mothers in the experimental group received routine breastfeeding care in addition to viewing an educational video on smoking cessation delivered through virtual reality glasses and a mobile application. The intervention aimed to increase awareness of the harmful effects of smoking on maternal and infant health and to support smoking cessation. Participants were followed for six months.
Receives: Behavioral: Virtual Reality and Mobile Application-Based Smoking Cessation Education
ControlNo interventionParticipants in the control group received routine breastfeeding care and standard counseling provided by the breastfeeding clinic. They did not receive the virtual reality- and mobile application-based smoking cessation education.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in nicotine dependence measured by the Fagerström Test for Nicotine Dependence (FTND)

    Nicotine dependence was assessed using the Fagerström Test for Nicotine Dependence (FTND). The primary outcome was the change in FTND score from baseline to the 6-month follow-up. Higher scores indicate greater nicotine dependence.

    Measured: Baseline, 1 month, 2 months, 4 months, and 6 months

  2. Change in Nicotine Dependence Measured by the Fagerström Test for Nicotine Dependence (FTND)

    The primary outcome was the change in nicotine dependence measured using the Fagerström Test for Nicotine Dependence (FTND). The FTND is a six-item questionnaire with total scores ranging from 0 to 10, where higher scores indicate greater nicotine dependence. Changes in FTND scores were compared between the intervention and control groups throughout the follow-up period.

    Measured: Baseline, 1 month, 2 months, 4 months, and 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Aug 2026
  2. Study start1 Jan 2026
  3. Primary completion1 Jan 2026
  4. Study completion1 Jan 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
76 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07775755
Sponsor's protocol ID
Virtual Reality Smoking Cessat
Status last verified
Jul 2026
First submitted
10 Jul 2026
Last updated
20 Aug 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Virtual Reality and Mobile Application-Based Smoking Cessation Education in people with Smoking Cessation and Tobacco Use Disorder, run by Kahramanmaras Sutcu Imam University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in nicotine dependence measured by the Fagerström Test for Nicotine Dependence (FTND) (time frame: Baseline, 1 month, 2 months, 4 months, and 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in